Kabre Rohit S, Kamble Krishna M
Department of Radiation Oncology, P.D. Hinduja Hospital, Mumbai, Maharashtra, India.
Department of Radiation Therapy and Oncology, Government Medical College and Hospital, Nagpur, Maharashtra, India.
South Asian J Cancer. 2019 Jul-Sep;8(3):195-197. doi: 10.4103/sajc.sajc_314_18.
There is scarcity of data regarding clinical presentation and outcome of retinoblastoma patients in India.
The objective of this study was to assess the clinical profile of retinoblastoma patients in a tertiary care hospital in India from 1983 to 2013.
A retrospective analysis of clinical records of 141 patients with retinoblastoma registered from 1983 to 2013 at Government Medical College, Nagpur, India, was conducted. Demographics, clinical features, modes of treatment, and outcome of the patients were assessed.
Majority of patients (81 [57.45%]) presented in the age group of 1-3 years and were males. One hundred and fourteen patients (80.85%) had unilateral disease, while rare presentations of trilateral/quadrilateral retinoblastoma were also noted. Proptosis was seen in 81 (57.45%) patients as presenting symptom. Eighty-nine patients (63.12%) had locally invasive disease-involving sites. Forty-four patients (31.19%) developed distant metastasis. Surgical management and external beam radiotherapy were followed in majority of patients. Trend of increased usage of chemotherapy was seen from the mid-1990s. One hundred and twelve patients (79.43%) died with the disease.
Data from this study show late diagnosis, leading to poor outcome for patients with advanced retinoblastoma, which is in accordance with data from other developing countries. Even though management of patients changed in accordance with changing standard of care over the decade, mortality remained high.
关于印度视网膜母细胞瘤患者的临床表现和预后的数据稀缺。
本研究的目的是评估1983年至2013年期间印度一家三级护理医院中视网膜母细胞瘤患者的临床特征。
对1983年至2013年在印度那格浦尔政府医学院登记的141例视网膜母细胞瘤患者的临床记录进行回顾性分析。评估患者的人口统计学、临床特征、治疗方式和预后。
大多数患者(81例[57.45%])年龄在1至3岁之间,且为男性。114例患者(80.85%)患有单侧疾病,同时也注意到了三侧/四侧视网膜母细胞瘤的罕见表现。81例患者(57.45%)出现眼球突出作为首发症状。89例患者(63.12%)有局部侵袭性疾病累及部位。44例患者(31.19%)发生远处转移。大多数患者采用手术治疗和外照射放疗。从20世纪90年代中期开始出现化疗使用增加的趋势。112例患者(79.43%)死于该疾病。
本研究数据显示诊断较晚,导致晚期视网膜母细胞瘤患者预后较差,这与其他发展中国家的数据一致。尽管在这十年间患者的治疗根据不断变化的护理标准有所改变,但死亡率仍然很高。